The misuse of benzodiazepines among adolescents: Psychosocial risk factors in a national sample

Drug and Alcohol Dependence

Volumn 137, Issue 1, 2014, Pages 137-142

  Rigg, Khary K ^a   Ford, Jason A ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Adolescents; Benzodiazepine misuse; Prescribing; Prescription medications; Prevention; Psychiatry; Risk factors; Social theory

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; ILLICIT DRUG; SEDATIVE AGENT;

ADOLESCENT; ARTICLE; BEHAVIOR THEORY; BINGE DRINKING; CANNABIS USE; CHILD; DEPRESSION; DRUG MISUSE; FEMALE; HUMAN; JUVENILE DELINQUENCY; MALE; PARENTAL ATTITUDE; PEER GROUP; PREVALENCE; PRIORITY JOURNAL; RELIGION; SOCIAL BONDING; SOCIAL BONDING THEORY; SOCIAL LEARNING THEORY; SOCIAL PSYCHOLOGY; STRAIN THEORY; TOBACCO USE; UNITED STATES; ADOLESCENT BEHAVIOR; EPIDEMIOLOGY; HEALTH SURVEY; PSYCHOLOGY; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; TRENDS;

ADOLESCENT; ADOLESCENT BEHAVIOR; BENZODIAZEPINES; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; MALE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84896067758     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.01.026     Document Type: Article

References (33)

1. Agnew R. Foundation for a general strain theory of crime and delinquency. Criminology 1992, 30:47-88.
2. Akers R.L., Lee G. Age, social learning, and social bonding in adolescent substance use. Deviant Behav. 1999, 19:1-25.
3. Akers R.L. Social Learning and Social Structure: A General Theory of Crime and Deviance 1998, Northeastern University Press, Boston, MA.
4. Ashton H. Benzodiazepine withdrawal: an unfinished story. BMJ 1984, 288:1135-1140.
5. Augustin S.G. Anxiety disorders. Applied Therapeutics: The Clinical Use of Drugs 2001, 74.1-74.48. Lippincott Williams & Wilkins, Philadelphia. M.A. Koda-Kimble, L.Y. Young, W.A. Kradjan, B.J. Guglielmo (Eds.).
6. Blazer D., Hybels C., Simonsick E., Hanlon J.T. Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison. J. Am. Geriatr. Soc. 2000, 48:1073-1079.
7. Brunette M.F., Noordsy D.L., Xie H., Drake R.E. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psych. Serv. 2003, 54:1395-1401.
8. Carson D.C., Sullivan C.J., Cochran J.K., Lersch K.M. General strain theory and the relationship between early victimization and drug use. Deviant Behav. 2008, 30:54-88.
9. Chen K.W., Berger C.C., Forde D.P., D'Adamo C., Weintraub E., Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry 2011, 11:90-97.
10. Clarot F., Goulle J.P., Vaz E., Proust B. Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality?. Forensic Sci Int. 2003, 134:57-61.
11. DeNavas-Walt C., Proctor B.D., Smith J.C. Income, Poverty, and Health Insurance Coverage in the United States: 2011 2012, US Department of Commerce Report, Washington, DC.
12. Ford J.A. Nonmedical prescription drug use among adolescents: the influence of bonds to family and school. Youth Soc. 2009, 40:336-352.
13. Ford J.A. Nonmedical prescription drug use and delinquency: an analysis with a national sample. J. Drug Issues 2008, 38:493-516.
14. Herman-Stahl M.A., Krebs C.P., Kroutil L.A., Heller D.C. Risk and protective factors for methamphetamine use and non-medical use of prescription stimulants among young adults aged 18 to 25. Addict. Behav. 2007, 32:1003-1015.
15. Hernandez S.H., Nelson L.S. Prescription drug abuse: insight into the epidemic. Clin. Pharmacol. Ther. 2010, 88:307-317.
16. Hirschi T. Causes of Delinquency 1969, University of California Press, Berkeley.
17. Lader M.H., Petursson H. Benzodiazepine derivatives - side effects and dangers. Biol. Psychiatry 1981, 16:1195-1201.
18. Longo, Johnson L.P. Addiction: part I. benzodiazepines - side effects, abuse risk and alternatives. Am. Fam. Physician 2000, 61:2121-2128.
19. McCabe S.E., West B.T., Cranford J.A., Ross-Durow P., Young A., Teter C.J., Boyd C.J. Medical misuse of controlled medications among adolescents. Arch. Pediatrics Adolesc. Med. 2011, 165:729.
20. McCabe S.E. Correlates of non-medical use of prescription benzodiazepine anxiolytics: results from a national survey of US college students. Drug Alcohol Depend. 2005, 79:53-62.
21. Olajide D., Lader M. Depression following withdrawal from long-term benzodiazepine use: a report of four cases. Psychol. Med. 1984, 14:937-940.
22. Ogle A., Moore K., Barrett B., Young M.S., Pearson J. Clinical history and characteristics of persons with oxycodone-related deaths in Hillsborough County, Florida in 2009. Forensic Sci. Int. 2012, 223:47-52.
23. Rigg K.K., Murphy J.W. Understanding the etiology of prescription opioid abuse: implications for prevention and treatment. Qual. Health Res. 2013, 23:963-975.
24. Rigg K.K., Ibañez G.E. Motivations for non-medical prescription drug use: a mixed methods analysis. J. Subst. Abuse Treat. 2010, 39:236-247.
25. Rooney S., Kelly G., Bamford L., Sloan D., O'Connor J.J. Co-abuse of opiates and benzodiazepines. Ir. J. Med. Sci. 1999, 168:36-41.
26. Schroeder R.D., Ford J.A. Prescription drug misuse a test of three competing criminological theories. J. Drug Issues 2012, 42:4-27.
27. Seal K.H., Shi Y., Cohen G., Cohen B.E., Maguen S., Krebs E.E., Neylan T.C. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012, 307:940-947.
28. Simoni-Wastila L.J., Ritter G., Strickler G. Gender and other factors associated with the non-medical use of abusable prescription drugs. Subst. Use Misuse 2004, 39:1-23.
29. Singh A.C. Maintaining analytic utility while protecting confidentiality of survey and nonsurvey data. J. Privacy Confidentiality 2009, 1:155-182.
30. Substance Abuse and Mental Health Services Administration Results from the 2010 National Survey of Drug Use and Health: Summary of National Findings, NSDUH Series H-41 HHS Publication No. (SMA) 11-4658 2011, Substance Abuse and, Rockville, MD.
31. Substance Abuse and Mental Health Services Administration Center for Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
32. Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality (June 2, 2011). The TEDS Report: Substance Abuse Treatment Admissions for Abuse of Benzodiazepines 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD.
33. Swartz M., Landerman R., George L.K., Melville M.L., Blazer D., Smith K. Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. Am. J. Public Health 1991, 81:592-596.